1,663
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas

, , , , , & show all
Pages 1344-1354 | Received 01 Feb 2015, Accepted 09 Mar 2015, Published online: 08 Apr 2015

References

  • Brinker AM, Ma J, Lipsky PE, et al. (2007). Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68:732–66
  • Chan EWC, Cheng SCS, Sin FWY, Xie Y. (2001). Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol Lett 122:81–7
  • Chang WT, Kang JJ, Lee KY, et al. (2000). Triptolide and chemotherapy cooperate in tumor cell apoptosis. J Biol Chem 276:2221–7
  • Chang XL, Chen HB, Zhao XZ, et al. (2005). High-performance liquid chromatography determination of triptolide in vitro permeation studies. Anal Chim Acta 534:215–21
  • Chen BJ. (2001). Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F. Leukemia Lymphoma 42:253–65
  • Chugh R, Sangwan V, Patil SP, et al. (2012). A preclinical evaluation of minnelide as a therapeutic agent against pancreatic cancer. Sci Transl Med 4:156ra139
  • Dan LW. (2005). Evolution of parenteral lipid emulsions. Clin Nutr Suppl 1:5–7
  • Floyd AG. (1999). Top ten considerations in the development of parenteral emulsions. Res Focus 2:134–43
  • Ju XY. (2007). Preparation of triptolide-liposome and its in vivo antitumor activity. Chin JMAP 24:271–4
  • Kupchan SM, Court WA, Dailey RG, et al. (1972). Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Terpterygium wilfordii. J Am Chem Soc 94:7194–5
  • Lee KY, Chang WT, Qiu D, et al. (1999). PG490 (Triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem 274:13451–5
  • Li D, Xie K, Wolff R, Abbruzzese JL. (2004). Pancreatic cancer. Lancet 363:1049–57
  • Li Q, Wang MQ, Duan LX, et al. (2009). Regional arterial infusion chemotherapy with lipid emulsion as a solvent for the treatment of advanced pancreatic cancer: a preliminary clinical study. J Intervent Radiol 18:275–7
  • Li XJ, Jiang ZZ, Zhang LY. (2014). Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol 155:67–9
  • Liu JH, Jiang RG, Wang CL. (2008). Improving pancreas targeting capability of hydroxycamptothecin using lipid emulsion as drug carrier. Chin Tradit Herb Drugs 39:844–7
  • Liu Q. (2011). Triptolide and its expanding multiple pharmacological functions. Int Imunopharmacol 11:377–83
  • Lu Y, Wang YJ, Tang X. (2007). Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E. Int J Pharm 346:47–56
  • Mujumdar N, Mackenzie TN, Dudeja V, et al. (2010). Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology 139:598–608
  • Phillips PA, Dudeja V, McCarroll JA, et al. (2007). Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res 67:9407–16
  • Shamon LA, Pezzuto JM, Graves JM, et al. (1997). Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 112:113–17
  • Shao F, Wang GJ, Sun JG, et al. (2007a). Pharmacokinetics of triptolide in Beagle dogs. Acta Pharm Sin 42:61–5
  • Shao F, Wang GJ, Xie HT, et al. (2007b). Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats. Biol Pharm Bull 30:702–7
  • Sun X, Zhang SM, Tian CH, et al. (2001). Safety of Tripterygium wilfordii. Chin J New Drugs 10:539–43
  • Takenaga M. (1996). Application of lipid microspheres for the treatment of cancer. Adv Drug Deliv Rev 20:209–19
  • Venkateswarlu V, Patlolla RR. (2001). Lipid microspheres as drug delivery systems. Ind J Pharm Sci 63:450–8
  • Vincent A, Herman J, Schulick R, et al. (2011). Pancreatic cancer. Lancet 378:607–20
  • Wang Z, Jin H, Xu R, et al. (2009). Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med 41:717–27
  • Wang ZH, Wen J, Xing JB, Guo D. (2005). Determination of triptolide and triptonide in human plasma by high-performance liquid chromatography. Biomed Chromatogr 19:60–2
  • Xu LY, Chen HB, Xu HB, Yang XL. (2008). Anti-tumor and immuno-modulation effects of triptolide-loaded polymeric micelles. Eur J Pharm Biopharm 70:741–8
  • Xu W, Xing FJ, Dong K, et al. (2014). Application of traditional Chinese medicine preparation in targeting drug delivery system. Drug Deliv Early Online:1–8. doi: 10.3109/10717544.2014.892545
  • Xue M, Zhao Y, Li XJ, et al. (2012). Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Eur J Pharm Sci 47:713–17
  • Yang S, Chen J, Guo Z, et al. (2003). Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2:65–72
  • Zhuang XM, Liu PX, Zhang YJ, et al. (2013). Simultaneous determination of triptolide and its prodrug MC002 in dog blood by LC–MS/MS and its application in pharmacokinetic studies. J Ethnopharmacol 150:131–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.